作者:
Schilder,R.J. [1]
;
Brady,W.E. [2]
;
Lankes,H.A. [3]
;
Fiorica,J.V. [4]
;
Shahin,M.S. [5]
;
Zhou,X.C. [6]
;
Mannel,R.S. [7]
;
Pathak,H.B. [8]
;
Hu,W. [9]
;
Alpaugh,R.K. ;
Sood,A.K. ;
Godwin,A.K.
作者单位:
Department of Gynecologic Oncology, Sarasota Memorial Hospital, Sarasota, FL 34239, United States
[1]
Fox Chase Cancer Center, Protocol Support Laboratory, Philadelphia, PA 19111, United States
[2]
Hanjani Institute for Gynecologic Oncology, Abington Memorial Hospital, Abington, PA 19001, United
[3]
Department of Gynecologic Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX
[4]
Department of OB/GYN, University of Oklahoma, Health Sciences Center, Oklahoma City, OK 73190
[5]
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States
[6]
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City
[7]
Department of Gynecologic Oncology, Hospital of Central Connecticut, New Britain, CT 06050, United
[8]
Gynecologic Oncology Group, Statistical and Data Center, Buffalo, NY 14263, United States
[9]
发布时间
2013-11-20